Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study

Open access

Abstract

BACKGROUND: Anxiety disorders have been linked to an increased risk of incident coronary heart disease in which inflammation plays a key pathogenic role. To date, no studies have looked at the association between proinflammatory markers and agoraphobia. METHODS: In a random Swiss population sample of 2890 persons (35-67 years, 53% women), we diagnosed a total of 124 individuals (4.3%) with agoraphobia using a validated semi-structured psychiatric interview. We also assessed socioeconomic status, traditional cardiovascular risk factors (i.e., body mass index, hypertension, blood glucose levels, total cholesterol/high-density lipoprotein-cholesterol ratio), and health behaviors (i.e., smoking, alcohol consumption, and physical activity), and other major psychiatric diseases (other anxiety disorders, major depressive disorder, drug dependence) which were treated as covariates in linear regression models. Circulating levels of inflammatory markers, statistically controlled for the baseline demographic and health-related measures, were determined at a mean follow-up of 5.5 ± 0.4 years (range 4.7 - 8.5). RESULTS: Individuals with agoraphobia had significantly higher follow-up levels of C-reactive protein (p = 0.007) and tumor-necrosis-factor-α (p = 0.042) as well as lower levels of the cardioprotective marker adiponectin (p = 0.032) than their non-agoraphobic counterparts. Follow-up levels of interleukin (IL)-1β and IL-6 did not significantly differ between the two groups. CONCLUSIONS: Our results suggest an increase in chronic low-grade inflammation in agoraphobia over time. Such a mechanism might link agoraphobia with an increased risk of atherosclerosis and coronary heart disease, and needs to be tested in longitudinal studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0123757

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 45

Metadata

Authors
Wagner, E.-Y. N., Wagner, J. T., Glaus, J., Vandeleur, C. L., Castelao, E., Strippoli, M.-P. F., Vollenweider, P., Preisig, M., & von Känel, R.
Affiliations
  • University Hospital of Bern (CH)
  • Swissmedic (CH)
  • Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Wagner, En-Young N.
Venue
PLOS ONE
Published
2015-04-13
Volume
10
Issue
4
Pages
e0123757
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2033541273
Cited by
40
References
52
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 2
FWCI
5.52
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, other-oa)
  • IRIS (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Access CRIS of the University of Bern
Funders
  • National Science Foundation (33CS30-139468, 33CS30-148401, 33CSCO-122661)
  • GlaxoSmithKline (33CSCO-122661, 33CS30-139468 and 33CS30-148401, 3200B0–105993, 33CSCO-122661, 3200B0-118308, 33CS30-148401, 33CS30-139468)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (148401, 122661, 33CSCO, 118308, 105993, 3200B0, 33CS30, 139468)
  • Chinese Society of Clinical Oncology
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
agoraphobia, low-grade inflammation, pro-inflammatory markers, C-reactive protein, TNF-α, adiponectin, interleukin-6, IL-1β, coronary heart disease risk, atherosclerosis, anxiety disorders, cardiovascular risk factors
MeSH terms
Adult, Aged, Agoraphobia, Chronic Disease, Female, Follow-Up Studies, Humans, Inflammation, Male, Middle Aged, Models, Biological, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study. https://app.cochat.ai/papers/10.1371/journal.pone.0123757
The paper
Wagner, E.-Y. N., Wagner, J. T., Glaus, J., Vandeleur, C. L., Castelao, E., Strippoli, M.-P. F., Vollenweider, P., Preisig, M., & von Känel, R. (2015). Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study. PLOS ONE. https://doi.org/10.1371/journal.pone.0123757

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.